Inactive Instrument
Tobira Therapeutics Inc Stock
Stocks
US88883P1012
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 55 | - |
Scott Reents
DFI | Director of Finance/CFO | 59 | - |
| Corporate Secretary | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.14% | -8.06% | +58.96% | +118.67% | 54.63B | |
| +1.84% | -0.66% | +75.79% | +93.87% | 54.88B | |
| -2.24% | +3.59% | +17.75% | +477.47% | 25.06B | |
| -1.60% | -6.21% | -18.96% | -15.21% | 23.14B | |
| +2.43% | +1.06% | +42.44% | -1.27% | 19.88B | |
| -3.19% | 0.00% | +35.60% | -26.98% | 17.55B | |
| -6.84% | +2.18% | +195.12% | +357.18% | 16.5B | |
| -1.05% | +1.16% | +25.95% | +194.27% | 14.2B | |
| +8.74% | +3.51% | +51.91% | +726.40% | 15.36B | |
| Average | -0.67% | -0.28% | +53.84% | +213.82% | 26.8B | |
| Weighted average by Cap. | -0.91% | -1.46% | +54.90% | +176.46% |
- Stock Market
- Stocks
- Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
